Trials / Completed
CompletedNCT04133402
Fertility After Intrauterine Tamponing Balloon: Where Are we
Evaluation of Fertility of Patients With a History of Postpartum Hemorrhage, Complicating Low-dose Delivery With Intrauterine Tamponade Treatment
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 59 (actual)
- Sponsor
- University Hospital, Lille · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Today, few data are available on the patient's fertility following intrauterine tamponade balloon (BTIU) used for postpartum hemorrhage (PPH) after vaginal delivery (AVB). Several studies have concluded that there are no fertility disorders after conservative surgical treatment or embolization. BTIU is an essential treatment in the management of PPH. The aim was to evaluate post-BTIU fertility and the appearance of gynecological symptoms. This is a bicentric retrospective study (Valenciennes, Lille, France), between 2012 and 2017. The data will be collected by telephone interview on fertility and various gynecological functional symptoms.
Conditions
Timeline
- Start date
- 2019-11-19
- Primary completion
- 2019-12-27
- Completion
- 2019-12-27
- First posted
- 2019-10-21
- Last updated
- 2020-07-01
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT04133402. Inclusion in this directory is not an endorsement.